Arcosa, Inc. (ACA) · Oct 23, 2026 · Acquisition
$7.5B acquisition — $150/share cash; approximately $7.5B paid
Arcosa’s acquisition by CRH is complete at $150 per share, with the stock delisted and the company moving fully under private ownership.
Arcosa is moving from a standalone infrastructure platform into CRH’s North American materials network. Its businesses span construction products and engineered structures serving aggregates, grid infrastructure, transmission, renewables, telecom and data-center-related demand. The filing makes that strategic story official rather than changing it: CRH now owns Arcosa outright. 〔0〕
| Filing figure | Detail |
|---|---|
| Merger consideration | $150.00 cash per share (Completion of Acquisition or Disposition of Assets) |
| Total equity consideration | Approximately $7.5 billion (Completion of Acquisition or Disposition of Assets) |
| Arcosa debt repaid | Approximately $450.1 million (Termination of a Material Definitive Agreement) |
| CRH acquisition funding | $3.25 billion bridge facility plus $2.5 billion term loan, with cash on hand (Changes in Control of Registrant) |
The main business consequence is ownership transfer, not an operating update. Shareholders receive $150 in cash, while Arcosa becomes a wholly owned subsidiary and its existing board and officers leave as part of the merger.
The public-company chapter is ending cleanly. Trading was halted before the October 23 opening, the shares are being removed from both NYSE listings, and Arcosa plans to terminate its remaining SEC reporting obligations. 〔1〕 The credit agreement was also fully repaid and terminated, with no material early-termination penalty. (Termination of a Material Definitive Agreement)
This is confirmation, not a surprise. The $150-per-share all-cash deal was announced on June 21, 2026, approved by stockholders on September 4, 2026, and the closing was therefore the expected final step rather than a new change in Arcosa’s business trajectory.
Bottom line: The filing completes the already-agreed sale of Arcosa to CRH and removes ACA from the public markets. It matters as a corporate endpoint, but adds little new information beyond confirming the transaction closed.
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!